Determination of unbound platinum after oxaliplatin administration: comparison of currently available methods and influence of various parameters.

Gamelin, E; Boisdron-Celle, M; Lebouil, A; Turcant, A; Cailleux, A; Krikorian, A; Brienza, S; Cvitkovic, E; Larra, F; Robert, J; Allain, P

Gamelin, E; Boisdron-Celle, M; Lebouil, A; Turcant, A; Cailleux, A; Krikorian, A; Brienza, S; Cvitkovic, E; Larra, F; Robert, J; Allain, P.

Affiliation

Gamelin E; Department of Medical Oncology and Clinical Pharmacology, Centre Paul-Papin, Centre Regional de Lutte Contre le Cancer, Angers, France.

Anticancer Drugs ; 9(3): 223-8, 1998 Mar.

Article in En | MEDLINE | ID: mdl-9625432

Subject(s)

Antineoplastic Agents/pharmacokinetics; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Colorectal Neoplasms/drug therapy; Organoplatinum Compounds/pharmacokinetics; Platinum/blood; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Fluorouracil/administration & dosage; Humans; Leucovorin/administration & dosage; Organoplatinum Compounds/administration & dosage; Organoplatinum Compounds/adverse effects; Oxaliplatin; Regression Analysis

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Organoplatinum Compounds / Platinum / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antineoplastic Agents Type of study: Clinical_trials / Diagnostic_studies / Guideline Language: En Journal: Anticancer Drugs Year: 1998 Type: Article Affiliation country: France

Search on Google

Add to My VHL

XML

PubMed Links